Background. Cilazapril, a converting enzyme inhibitor, has been shown to significantly decrease the extent of intimal smooth muscle cell proliferation after arterial injury in a normotensive rat model.
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Background. Cilazapril, a converting enzyme inhibitor, has been shown to significantly decrease the extent of intimal smooth muscle cell proliferation after arterial injury in a normotensive rat model. Methods and Results. To assess the influence of cilazapril on myofibrotic changes after balloon injury, control (n=7) or cilazapril-treated (n=9) (20 mg/kg b.i.d.) normal 3-month-old pigs underwent dilatation angioplasty of the right, and deendothelialization of the left common carotid artery. Carotid arteries isolated at 4 weeks were examined morphometrically with a computerized digitizer after in situ glutaraldehyde fixation. Both in the deendothelialized and dilated arteries, the surface area in square millimeters of the neointima and media were similar in the treated and control animals; therefore, the ratio of neointima to media was again not different. The neointimal changes included a combination of proliferative changes as well as organization of mural thrombus and were equally well distributed in the two groups of animals. At the time that the animals were killed, blood pressure (38.2±2.1 versus 56.8±4.8 mm Hg, p =0.003) and plasma angiotensin converting enzyme activity (5.6±4.1 versus 182.3±70.4, p =0.02) were lower in treated than in control pigs, but aortic media thrombogenicity (as assessed in an ex vivo perfusion flow chamber) and serum lipids were not different between groups. Conclusions. In pigs, cilazapril did not alter the development of myofibrotic changes after mild or severe balloon injury despite plasma angiotensin converting enzyme 
Tissue Analysis
At the end of the study, the animals were killed and the carotid arteries were perfused anterogradely with 2% glutaraldehyde and 1% paraformaldehyde in 0.1 M cacodylate (pH 7.25) buffer at physiological pressure to fix the arteries in situ. The nonperfused thoracic/abdominal aorta was removed together with the fixed carotid arteries, which were cleaned and prepared for analysis. Serial equally spaced ring sections of the injured carotid arteries between the fifth and the fourth cervical vertebrae were stained with hematoxylinfloxin-safran and Movat pentachrome stains, which define the boundaries between the neointima and the media. Morphometric analysis of the histological crosssections of the dilated right and mildly injured left common carotid arteries was performed using a computerized digitizer to planimeter the surface area of the neointima and media. First, the histological cross-sections were projected onto white paper by using a Tri-simplex microprojector (Bausch and Lomb, Rochester, N.Y.) at 40x magnification. The luminal perimeter as well as the internal and outermost external elastic laminae were traced. The tracings were then transposed over a digitizing tablet interfaced to an IBM AT microcomputer loaded with a commercial software package (Sigman Scan) in which the outlines were retraced. The digitizing tablet was calibrated before each measurement. The cross-sectional area (in square millimeters) of the neointima was obtained by subtracting the luminal area from that bounded by the internal elastic lamina and the medial area by subtracting the area bounded by the internal elastic lamina from that of the external elastic lamina. Measurements were performed blinded to treatment assignment. Six different histological cross-sections were analyzed per carotid artery segment injured, and the mean value was calculated for the neointimal area, medial area, and the ratio of neointima to media.
Aortic Media Thrombogenicity
The thrombogenicity of the nonfixed aortic media harvested from the treated and control animals at the time the animals were killed was assessed in an ex vivo superfusion flow chamber by using femoral arterial blood from a normal untreated pig. The arterial blood was drawn into Plexiglas superfusion chambers by a peristaltic pump (model 7013, Masterflex) and recirculated into the animal through the femoral vein. The cylindrical superfusion Plexiglas chambers were designed to mimic the tubelike shape of the vascular system and contain a window permitting direct exposure of the aortic media to the flowing femoral arterial blood, which was kept constant by the peristaltic pump. 19 The internal diameter of the chamber was 1.0 mm, with a flow rate set at 20 ml per minute; the theoretically calculated shear rate was 3,360 sec`l. A 5-minute superfusion was performed with the chamber kept at 37°C in a water bath. The aortic media used in the superfusion chambers was prepared by lifting up and peeling off the intima together with a thin portion of the subjacent media after longitudinally opening the aorta. The exposed media overlying the adventitia was then divided into 35 x 15 -mm segments to be placed inside the superfusion chambers.
Platelet thrombus deposition on the aortic media was quantitated using`'In-labeled autologous platelets injected into the normal untreated animal 18 hours before using its femoral arterial blood for the superfusion experiment. Platelets were labeled according to previously described techniques. [17] [18] [19] 21 .8±5.2 nmol/l/sec. This activity continued to decline to attain a minimum activity at about 4-6 hours after dosing (2.2+1.2-1.3±0.8 nmol/1/sec, respectively). This inhibition of the angiotensin converting enzyme activity persisted throughout the 11-hour period assessed and was 2.5 ± 1.4 nmol/l/sec 11 hours after drug ingestion. Therefore, the twice-daily dosing regimen used assured continuous suppression of the enzyme activity over a 24-hour period.
At the end of the study, that is, after 5 weeks of treatment with cilazapril, plasma angiotensin converting enzyme activity was significantly lower in the treated animals than in the controls, with an inhibition in excess of 96% of the plasma enzyme activity of control animals ( Figure 1) .
Mean femoral arterial blood pressure was similar in the treated and control animals before the study (62.4±3.5 versus 61.8±4.0 mm Hg, respectively;p=NS). However, at the end of the study, mean arterial pressure was significantly lower in the treated animals (38.2±2.1 mm Hg) relative to the control animals (56.8±4.8 mm Hg,p=0.003). Heart rate was similar in the treated and control animals before (85.9±4.6 versus 78.9±4.2 beats per minute, p=NS) and at the end of the study (70.7±5.8 versus 74.8±6.6 beats per minute, respectively; p=NS).
Four weeks after both the superficial or mild and deep or severe arterial injury, extensive neointimal thickening characterized by a combination of fibrocellular proliferation, extracellular matrix accumulation, and organization of mural thrombus3 (Figures 2A, 2B , and 2C) was observed at the site of vessel injury. After the superficial injury, the surface area of the neointima and the media were similar (p=NS) in the treated and control animals; therefore, the ratio of neointima to media was not different (Figure 3 ). Changes occurring after 4 weeks in the deeply injured arteries were again similar (p=NS) in the treated and control animals ( Figure 4) . Although the neointimal changes in the control animals were somewhat less than in the treated animals, they were not statistically significant.
These neointimal changes were not associated with any changes in serum total cholesterol before ( 
Discussion
Injury to blood vessels appears to produce a stereotypical response leading to marked intimal thickening, a process that is believed to reflect one of the early stages in the development of atherosclerosis.12 This process appears to develop independently of the type of vessel wall injury (immunological or mechanical) and has been demonstrated in a number of animal models, including the rat, rabbit, swine, and in humans after coronary angioplasty and saphenous vein aortocoronary bypass surgery.'-8 In the present study using normolipemic swine, significant neointimal thickening is observed at 4 weeks after balloon injury, confirming previous reports.3 However, the data presented also show that these neointimal changes were not modified by pretreatment with the angiotensin converting enzyme inhibitor cilazapril. The extent of neointimal thickening was unchanged after either mild or severe balloon injury despite adequate drug absorption as shown by the almost complete inhibition of the plasma angiotensin converting enzyme activity and the significant depression of mean arterial pressure.
The twice-daily regimen of cilazapril used in this study was selected to provide continuous suppression of angiotensin converting enzyme and to achieve a lowering of blood pressure response throughout the day. At the end of the study, plasma angiotensin converting enzyme activity was indeed markedly depressed, as was the physiological parameter of blood pressure. The absence of a beneficial effect of cilazapril on the development of neointimal hyperplasia in this study differs from the observations previously reported by Powell et al8 in rats. Although it is possible that a significant lowering of blood pressure may contribute to the observed decrease in neointimal changes after cilazapril or hydralazine treatment in the rat model,8'13 it is less likely that such a mechanism was operative in this study in which a significant 39% fall in blood pressure produced no significant change in neointimal thickening. Similar to the Powell study,8 however, which has shown the need for continuous administration of cilazapril during the response of the vascular wall, cilazapril was started 7 days before vessel wall injury and then continued for the 4 weeks of the study. In Powell'ss and Chobanian's2' studies, a large difference in atherosclerosis development in favor of drug therapy was observed. This was a very significant difference (p<O.OOO1) with the 22 animals evaluated. However, in our study involving 16 animals, the extent of neointima formation as well as the ratio of neointima to media tended to be higher in the treated group than in the control group for both the mild and severe injury. Because of this potentially adverse effect of drug therapy, it becomes very unlikely that a beneficial treatment effect (even at the level of p<O.05) could be demonstrated even if the number of animals was increased; thus, it is unlikely that this negative study was due to a type II error. In addition, a similar dose of cilazapril was used, which is almost 100 times the equivalent dose that might be used in the clinical setting. This high dose of cilazapril used in the 16 Therefore, intimal thickening and restenosis after angioplasty is believed to be a multifactorial process involving not only the vessel wall and its interaction with circulating blood elements but also its interaction with growth factors that influence cellular proliferation.1-16 The actual role and relative importance of these various factors in humans and in animal models must be defined, and different mechanisms may assume increasing importance in each of the various conditions. Many of these factors may even mimic or amplify the effects of each other. It is unclear whether the renin-angiotensin system can influence or modulate the platelet-vessel wall interaction or the effects of other growth factors in vivo. In swine, angioplasty as performed in this study causes acute platelet thrombus deposition,317"18 which may contribute to intimal thickening both by thrombus reorganization and by the release of mitogenic platelet-derived growth factor (PDGF) and other growth factors from the platelet-rich thrombus stimulating intimal hyperplasia.3,24,25 In a rabbit model, Liu et al '5 have shown that trapidil, which can inhibit PDGF-induced cellular proliferation in vitro, can also prevent the development of restenosis in vivo.i5 Besides the release of PDGF,1 platelets may influence vascular smooth muscle cell growth by the release of other mitogens such as serotonin,14 transforming growth factor B,1026-28 epidermal growth factor,26-28 and release of growth-inhibiting heparin from the endothelial cells.29 However, a plateletmediated process may not be the only mechanism involved in the swine model, and it would have been interesting to assess the influence of heparin'2,30 or hirudin, a direct thrombin inhibitor, alone and in combination with cilazapril, to appreciate the relative importance of these mechanisms in this animal model. It is of interest that in rabbits, hirudin has recently been shown to decrease restenosis. 31 The loss of endogenous growth inhibitors29 as well as the release of mitogenic factors from injured and dying endothelial cells may also contribute to smooth muscle growth. 27 Restenosis after angioplasty and intravascular stenting is a major problem limiting the expanded use of these procedures. However, an ideal animal model for the study of human atherosclerosis and the phenomenon of restenosis after angioplasty does not exist at present. Rabbits, dogs, or rats have been used previously.1-4 None of these animals develop atherosclerosis naturally, and in the atherosclerotic rabbit model, foam cell lesions predominate in association with a serum cholesterol level in excess of 1,000 mg/dl. 16, 19 Although the intimal changes observed in the rats may reflect mainly a response to mild injury,8413 it is unclear whether more severe injury as occurs in humans will result in a similar or more aggressive response. In this study, pigs were used: These animals develop atherosclerosis spontaneously without cholesterol feeding, and the similarity of their platelet coagulation system to that of humans may provide a closer approximation of the platelet coagulation system interactions with the vessel wall at the site of injury. Both mild and severe injury can be readily performed, although when used at 2-3 months of age, atherosclerotic lesions were not present.
Conclusions
Both mild and severe carotid arterial injury in pigs promote the development of intimal thickening that is not affected by pretreatment with the converting enzyme inhibitor cilazapril. The clinical significance of these findings is unknown. However, these data and methods may provide some useful insights not only into the relevance of animal models of injury to human arterial disease caused by vessel wall injury, such as by balloon angioplasty, but also into the mechanisms of drug effects in current clinical trials using cilazapril in the prevention of coronary arterial restenosis in humans.
